Bim directly counteracts anti-apoptotic Bcl-xl in doxorubicin-induced apoptosis independently of p53 in prostate cancer cell lines PC3 and LNCaP and inhibition of Bim resulted in inhibition of caspase activation and apoptosis in these cell lines [32]. This evidence concerns the gene BCL2L11 and prostate cancer.